English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Summary  The action of 0-beta-hydroxyethyl-rutosides (HR) on diabetic retinopathy has been evaluated on 20 diabetic patients by means of fluoresceinography. — The natural evolution and the evolution after treatment with HR (2400 mg orally per day) have been compared during periods of observation of 2 months. The administration of the medication and placebo, as well as the interpretation of the results, has been carried out on a double-blind basis. — The administration of HR causes a statistically significant reduction of the retinal vascular permeability to fluorescein.

Diabetic retinopathy: Study of the action of 0-betahydroxyethyl-rutosides (HR) by retinal fluoresceinography